Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia Read more about Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Thalassemia
Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma Read more about Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing Glioma
Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients Read more about Agios Announces Publication of TIBSOVO® Phase 3 Data in The Lancet Oncology Demonstrating Significant Improvement in Progression-Free Survival Compared to Placebo in Previously Treated IDH1-Mutant Cholangiocarcinoma Patients
Agios to Present Updated Clinical Proof-of-Concept Data from the Phase 2 Study of Mitapivat in Thalassemia in Oral Presentation at the European Hematology Association Annual Congress Read more about Agios to Present Updated Clinical Proof-of-Concept Data from the Phase 2 Study of Mitapivat in Thalassemia in Oral Presentation at the European Hematology Association Annual Congress
Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting Read more about Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting
Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020 Read more about Agios to Present at the RBC Capital Markets Global Healthcare Virtual Conference on Tuesday, May 19, 2020
Agios at RBC Capital Markets 2020 Global Healthcare Conference Read more about Agios at RBC Capital Markets 2020 Global Healthcare Conference
Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response Read more about Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response
Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020 Read more about Agios to Webcast Conference Call of First Quarter 2020 Financial Results on April 30, 2020